Clinical Relevance of Typing HLA-DR7-DQ2

Clinical trial NCT01813383 · COMPLETED

Trial details

NCT number: NCT01813383
Sponsor: Corporacion Parc Tauli
Status: COMPLETED
Study type: OBSERVATIONAL

Celiac Disease Patients Following Recommendations of ESPGHAN HLA-DQ2 Typing Include HLA-DR7-DQ2 Haplotypes

Start date: 2010-01-01
Primary completion: 2012-12-01
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.